Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Daanish Hoda"'
Autor:
Leo I. Gordon, Fei Fei Liu, Julia Braverman, Daanish Hoda, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C. Hildebrandt, Lily Peng, Shien Guo, Ling Shi, Alison Sehgal
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
In the single-arm, open-label, multicenter, phase II PILOT study, second-line treatment with the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel) in patients with relapsed or refractory (R/R) large B-cell lymphoma (L
Externí odkaz:
https://doaj.org/article/f85d926987c6464784c910fa8b1e7fda
Autor:
Lori Leslie, Michael Tees, Ian W. Flinn, Tulio Rodriguez, John H. Baird, Abhinav Deol, Monica Mead, Carlos Bachier, Aaron P. Rapoport, Brian Mcclune, Daanish Hoda, Miguel-Angel Perales, Yan Zheng, Simone Filosto, Madison Davis, Harry Miao, Jenny J. Kim, Olalekan O. Oluwole
Publikováno v:
HemaSphere, Vol 7, p e50042ff (2023)
Externí odkaz:
https://doaj.org/article/cf51f2eb81ef4620b604ac78295b8d69
Autor:
Bradley D. Hunter, Daanish Hoda, Andy Nguyen, Launce Gouw, Bryan Huber, Ryan R. Jensen, Justine Preedit, Andrew Evens, Esther Huang, Jiyeon Park, Dennis L. Cooper
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-3 (2022)
Abstract Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of relapsed/refractory B-cell malignancies. However, there is no data on the safety and efficacy of CAR T-cell therapy in patients with end stage renal disease (
Externí odkaz:
https://doaj.org/article/a04ca38722904367887186044b77dc43
Autor:
Wesley H. Self, Thomas G. Stewart, Allison P. Wheeler, Wissam El Atrouni, Amanda J. Bistran-Hall, Jonathan D. Casey, Vince D. Cataldo, James D. Chappell, Claudia S. Cohn, Jessica B. Collins, Mark R. Denison, Marjolein de Wit, Sheri L. Dixon, Abhijit Duggal, Terri L. Edwards, Magali J. Fontaine, Adit A. Ginde, Michelle S. Harkins, Thelma Harrington, Estelle S. Harris, Daanish Hoda, Tina S. Ipe, Stuti J. Jaiswal, Nicholas J. Johnson, Alan E. Jones, Maryrose Laguio-Vila, Christopher J. Lindsell, Jason Mallada, Manoj J. Mammen, Ryan A. Metcalf, Elizabeth A. Middleton, Simon Mucha, Hollis R. O’Neal, Sonal R. Pannu, Jill M. Pulley, Xian Qiao, Jay S. Raval, Jillian P. Rhoads, Harry Schrager, Carl Shanholtz, Nathan I. Shapiro, Stephen J. Schrantz, Isaac Thomsen, Krista K. Vermillion, Gordon R. Bernard, Todd W. Rice, For the Passive Immunity Trial for Our Nation (PassITON) Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Convalescent plasma is being used widely as a treatment for coronavirus disease 2019 (COVID-19). However, the clinical efficacy of COVID-19 convalescent plasma is unclear. Methods The Passive Immunity Trial for Our Nation (PassITO
Externí odkaz:
https://doaj.org/article/09f00f69e5d142a1b19dcc01b4acebd6
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 6, Pp 1221-1227 (2008)
Daanish Hoda1, George R Simon1, Christopher R Garrett1,21Division of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 2Current affiliation: Department of Gastrointestinal Oncology, The University of Tex
Externí odkaz:
https://doaj.org/article/5f8fb164de014f6ba6dcdee6225e3375
Autor:
Wesley H. Self, Allison P. Wheeler, Thomas G. Stewart, Harry Schrager, Jason Mallada, Christopher B. Thomas, Vince D. Cataldo, Hollis R. O’Neal, Nathan I. Shapiro, Conor Higgins, Adit A. Ginde, Lakshmi Chauhan, Nicholas J. Johnson, Daniel J. Henning, Stuti J. Jaiswal, Manoj J. Mammen, Estelle S. Harris, Sonal R. Pannu, Maryrose Laguio-Vila, Wissam El Atrouni, Marjolein de Wit, Daanish Hoda, Claudia S. Cohn, Carla McWilliams, Carl Shanholtz, Alan E. Jones, Jay S. Raval, Simon Mucha, Tina S. Ipe, Xian Qiao, Stephen J. Schrantz, Aarthi Shenoy, Richard D. Fremont, Eric J. Brady, Robert H. Carnahan, James D. Chappell, James E. Crowe, Mark R. Denison, Pavlo Gilchuk, Laura J. Stevens, Rachel E. Sutton, Isaac Thomsen, Sandra M. Yoder, Amanda J. Bistran-Hall, Jonathan D. Casey, Christopher J. Lindsell, Li Wang, Jill M. Pulley, Jillian P. Rhoads, Gordon R. Bernard, Todd W. Rice
Publikováno v:
Chest. 162:982-994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::605fa1aab8123b5041f56e61606714d7
https://doi.org/10.1016/j.chest.2022.06.029
https://doi.org/10.1016/j.chest.2022.06.029
Autor:
Alison, Sehgal, Daanish, Hoda, Peter A, Riedell, Nilanjan, Ghosh, Mehdi, Hamadani, Gerhard C, Hildebrandt, John E, Godwin, Patrick M, Reagan, Nina, Wagner-Johnston, James, Essell, Rajneesh, Nath, Scott R, Solomon, Rebecca, Champion, Edward, Licitra, Suzanne, Fanning, Neel, Gupta, Ronald, Dubowy, Aleco, D'Andrea, Lei, Wang, Ken, Ogasawara, Jerill, Thorpe, Leo I, Gordon
Publikováno v:
The Lancet Oncology. 23:1066-1077
Patients with relapsed or refractory large B-cell lymphoma after first-line treatment who are not intended for haematopoietic stem-cell transplantation (HSCT) have poor outcomes and limited treatment options. We assessed the antitumour activity and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7048a30eddf5ad18755f1aba03ca478
https://doi.org/10.1016/s1470-2045(22)00339-4
https://doi.org/10.1016/s1470-2045(22)00339-4
Publikováno v:
Transplantation and Cellular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da0b1892767909e57bb470eaa1996bb7
https://doi.org/10.1016/j.jtct.2023.04.010
https://doi.org/10.1016/j.jtct.2023.04.010
Autor:
Yuliya Linhares, Cesar Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Daanish Hoda, Juan Carlos Varela, Courtney Bellomo, Scott Cross, James Essell, Suzanne Fanning, Howard Terebelo, Habte Yimer, Jay Courtright, Jeff P. Sharman, Min Vedal, Connor Mailley, Ricardo Espinola, Bassam Mattar
Publikováno v:
Blood. 140:10416-10418
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26fcb71bb86551435eae1ac8c0814967
https://doi.org/10.1182/blood-2022-159595
https://doi.org/10.1182/blood-2022-159595
Autor:
M. Fung, Nosha Farhadfar, Joseph Pidala, Lisette M. Acevedo, Edmund K. Waller, Trent P Wang, Mark A. Schroeder, Jeremy Pantin, John Koreth, Cherie Tracy Ng, Marco Mielcarek, Alison W. Loren, Gabrielle Meyers, Joel Rothman, Krishna R. Polu, Stephen Connelly, Ryotaro Nakamura, Corey Cutler, George Chen, Daanish Hoda, Sarah Anand
Publikováno v:
Bone Marrow Transplantation. 56:369-374
Background: CD6 is a co-stimulatory receptor predominantly expressed on T cells. CD6high CD4+ T cells were recently shown to drive Th1/Th17 immune responses in inflammatory bowel disease and may have a similar role in acute graft-versus-host disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aa20cd0970ad8f6d6c335a87bad743f
https://doi.org/10.1038/s41409-021-01348-0
https://doi.org/10.1038/s41409-021-01348-0